Research published today in the journal Brain reveals a new approach to Alzheimer's disease (AD) that may eventually make it possible to reverse memory loss, a hallmark of the disease in its late stages.
Jan 22, 2019
2
4637
A new study shows that healthy people who take attention deficit hyperactivity disorder (ADHD) drugs experience a surge in the neurotransmitter glutamate in key parts of the brain. And that increase in glutamate is associated ...
Mar 14, 2018
1
1275
A research team from University of Lausanne (UNIL) and the Wyss Center, has discovered a new type of cell essential for brain function. Hybrid in composition and function, in between the two types of brain cells known so ...
Sep 6, 2023
0
559
(Medical Xpress)—Many chronically depressed and treatment-resistant patients experience immediate relief from symptoms after taking small amounts of the drug ketamine. For a decade, scientists have been trying to explain ...
Oct 4, 2012
13
2
New research from the Djavad Mowafaghian Centre for Brain Health at UBC has found a way to partially restore brain cell communication around areas damaged by plaques associated with Alzheimer's disease.
Nov 15, 2016
4
1478
The brains of healthy relatives of people with schizophrenia may hold a clue to better understand - and ultimately treat - the devastating illness, finds new research led by a Michigan State University scientist.
Jun 7, 2016
0
1001
(Medical Xpress)—'Where' and 'how' memories are encoded in a nervous system is one of the most challenging questions in biological research. The formation and recall of associative memories is essential for an independent ...
Aug 27, 2013
0
0
In a series of recently published studies using animals and people, Johns Hopkins Medicine researchers say they have further characterized a set of chemical imbalances in the brains of people with schizophrenia related to ...
May 8, 2019
0
5958
The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines ...
Jun 17, 2013
12
0
Scientists at the University of Cambridge have used powerful new brain imaging techniques to reveal a neurochemical imbalance within regions of the frontal lobes in patients with obsessive-compulsive disorder (OCD). The research ...
Jun 27, 2023
0
797
